LENSAR, Inc. (LNSR) stock
LNSRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3023% below fair value
$4.85−0.06 (-1.22%)
Close on Nov 18, 2026Market cap $59.59MP/E –Yield –
Lensar pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Lensar's pe ratio was 1.6× on Nov 11, 2026.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.6× | – |
See a number that looks wrong?